Date published: 2025-9-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

MANEAL Inhibitors

Chemical inhibitors of Glycoprotein endo-alpha-1,2-mannosidase-like protein (MANEAL) encompass a range of compounds that indirectly target the glycoprotein processing pathways in which MANEAL is functionally involved. Swainsonine, an inhibitor of alpha-mannosidase II, can inhibit MANEAL by disrupting glycoprotein processing in the Golgi apparatus, a crucial area of MANEAL activity. Similarly, Kifunensine, as a mannosidase I inhibitor, impacts the initial steps of N-linked glycan processing, thereby potentially inhibiting MANEAL's role in this process. Deoxymannojirimycin and Deoxynojirimycin, both targeting alpha-mannosidase, could inhibit MANEAL by disrupting its role in the maturation of N-linked glycans, a key part of glycoprotein processing. Castanospermine, an inhibitor of beta-glucosidase, might indirectly inhibit MANEAL by affecting pathways involved in N-linked glycan modification, while 1-Deoxynojirimycin, another alpha-mannosidase inhibitor, could similarly disrupt MANEAL's function in processing N-linked glycans.

Additionally, Miglustat, by inhibiting glucosylceramide synthase, may alter glycolipid metabolism, indirectly impacting MANEAL's activity in glycoprotein processing. Alpha-glucosidase inhibitors such as Voglibose and Acarbose can inhibit MANEAL by affecting pathways involved in N-linked glycan maturation, a process integral to glycoprotein processing. Salbostatin, as a trehalase inhibitor, could also influence glycoprotein processing pathways, particularly those involving N-linked glycan modification, thereby inhibiting MANEAL. Pyrrolidine dithiocarbamate, an NF-kB inhibitor, might indirectly inhibit MANEAL by affecting signaling pathways that regulate glycoprotein processing. Brefeldin A, known for inhibiting protein transport from the endoplasmic reticulum to the Golgi, could disrupt essential pathways for MANEAL's function in glycoprotein processing. Each of these chemicals, through their impact on specific biochemical pathways or cellular processes, converges to potentially inhibit the functional role of MANEAL in glycoprotein processing, a critical aspect of cellular function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Swainsonine

72741-87-8sc-201362
sc-201362C
sc-201362A
sc-201362D
sc-201362B
1 mg
2 mg
5 mg
10 mg
25 mg
$135.00
$246.00
$619.00
$799.00
$1796.00
6
(1)

Swainsonine, an inhibitor of alpha-mannosidase II, could inhibit MANEAL by disrupting glycoprotein processing in the Golgi apparatus, a pathway in which MANEAL is involved.

Kifunensine

109944-15-2sc-201364
sc-201364A
sc-201364B
sc-201364C
1 mg
5 mg
10 mg
100 mg
$132.00
$529.00
$1005.00
$6125.00
25
(2)

Kifunensine, a mannosidase I inhibitor, may inhibit MANEAL by affecting the initial steps of N-linked glycan processing, a process where MANEAL plays a role.

Deoxymannojirimycin hydrochloride

84444-90-6sc-201360
sc-201360A
1 mg
5 mg
$93.00
$239.00
2
(0)

Deoxymannojirimycin, targeting alpha-mannosidase, could inhibit MANEAL by disrupting its role in the processing and maturation of N-linked glycans.

Castanospermine

79831-76-8sc-201358
sc-201358A
100 mg
500 mg
$180.00
$620.00
10
(1)

Castanospermine, an inhibitor of beta-glucosidase, could indirectly inhibit MANEAL by affecting glycoprotein processing pathways, especially in N-linked glycan modification.

Deoxynojirimycin

19130-96-2sc-201369
sc-201369A
1 mg
5 mg
$72.00
$142.00
(0)

1-Deoxynojirimycin, an alpha-mannosidase inhibitor, could disrupt MANEAL's function in the processing of N-linked glycans.

Voglibose

83480-29-9sc-204384
sc-204384A
10 mg
50 mg
$194.00
$668.00
(1)

Voglibose, an alpha-glucosidase inhibitor, could inhibit MANEAL by impacting glycoprotein processing pathways, particularly those involving N-linked glycan maturation.

Acarbose

56180-94-0sc-203492
sc-203492A
1 g
5 g
$222.00
$593.00
1
(1)

Acarbose, another alpha-glucosidase inhibitor, might inhibit MANEAL by affecting glycoprotein processing and N-linked glycan modification.

Pyrrolidinedithiocarbamic acid ammonium salt

5108-96-3sc-203224
sc-203224A
5 g
25 g
$32.00
$63.00
11
(1)

Pyrrolidine dithiocarbamate, a NF-kB inhibitor, may indirectly inhibit MANEAL by affecting signaling pathways that regulate glycoprotein processing.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Brefeldin A, inhibiting protein transport from the endoplasmic reticulum to the Golgi, could disrupt the pathway integral to MANEAL's function in glycoprotein processing.